INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Stop Guessing On Trial Feasibility Simulating Patient Recruitment With AI]( "Stop Guessing On Trial Feasibility: Simulating Patient Recruitment With AI")
Stop Guessing On Trial Feasibility: Simulating Patient Recruitment With AISimulate enrollment, endpoints, and criteria with integrated data and synthetic populations to test protocol feasibility early — refining design and reducing recruitment and regulatory risks.
-
![Meeting, team, medical case review, treatment plan, research-GettyImages-2265129844]( "Why Operational Expertise Defines Great Clinical Trial Services")
Why Operational Expertise Defines Great Clinical Trial ServicesGreat trial technology isn't enough on its own. See why the operational expertise behind it can make or break your study's success.
-
![EmVenio community based sites]( "DCTs And Community-Based Research Execution And Compliance")
DCTs And Community-Based Research Execution And ComplianceThe FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
![From Chaos to clarity]( "From Chaos To Clarity: A Founder's View From 30 Years In Drug Development")
From Chaos To Clarity: A Founder's View From 30 Years In Drug DevelopmentSame workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.
-
Scaling Pharmacovigilance: Clinical Development To Commercialization10/1/2026
Commercial growth brings new PV challenges. Gain practical insights on operating models, technology, governance, and leadership for long-term success.
-
Powering Complex Personalized Medicine Oncology Trial2/25/2026
Managing custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.
-
Illuminating IHC: From Biomarker To Clinical Trial Assay5/2/2025
Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.
-
What If Therapeutic Area Expertise Isn't The Competitive Advantage We Think It Is?8/13/2026
Rethink vendor evaluation by looking beyond indication experience to discover how cross-trial adaptability, proactive risk management, and team judgment drive true clinical trial resilience.
-
From Weeks To Days: An Innovative Approach To Patient Recruitment10/28/2025
Discover how AI-driven, personalized communication can break linguistic and literacy barriers to make patient recruitment faster, more inclusive, and 30% more effective.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1388184871-quality-compliance-approval]( "Reviewing Protocols Across Therapeutic Areas")
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
![GettyIMages-1216658919 neurology]( "Driving Successful In CNS And Neurology Trials")
Second, only to Oncology, CNS, and Neurology clinical trials are incredibly complex and complicated to navigate.
-
![GettyImages-1135140461-lab-team]( "Accelerate Approval Of Novel Therapies")
Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase new therapies' probability of success.
-
![GettyImages-956015576 knee altasciences_edited]( "Selecting The Right Pain Model For Early Phase Analgesic Trials")
Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
-
![New Anti-Cancer Drug Shows Promising Results With Low Toxicity]( "Bold Thinking Overcomes Oncology Clinical Development Challenges")
Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.
